胰十二指肠切除术中靶向抗生素预防对比标准抗生素预防减少术后感染并发症的系统综述与Meta分析
该系统综述与Meta分析纳入7项研究共849例胰十二指肠切除术患者,比较靶向抗生素与标准围手术期抗生素对术后手术部位感染(SSI)的影响。靶向抗生素组SSI发生率显著低于标准抗生素组(21.1% vs 41.9%;RR 0.55,95%CI 0.37-0.81),伤口/切口感染和器官腔隙感染均降低。结论认为标准抗生素预防不足以覆盖术后感染常见微生物。
要点
- 靶向抗生素可显著降低胰十二指肠切除术后SSI发生率(RR 0.55)。
- 伤口/切口感染和器官腔隙感染在靶向抗生素组均更低。
- 肠球菌属是术后感染最常见的细菌。
核心结论
- 使用靶向抗生素时总体SSI率显著降低。
- 当前标准抗生素预防不足以覆盖胰十二指肠切除术后感染常见微生物。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE和Cochrane图书馆(1946年至2020年7月)。
- 纳入7项比较靶向抗生素与标准围手术期抗生素并报告SSI结局的研究,共849例胰十二指肠切除术患者。
- 靶向治疗定义为针对胆道器械操作中流行微生物或基于患者/机构培养数据的围手术期抗生素。
主要发现
- 靶向抗生素组SSI发生率为21.1%,标准抗生素组为41.9%(RR 0.55,95%CI 0.37-0.81)。
- 伤口/切口部位感染在靶向抗生素组更低(RR 0.33,P=0.0002)。
- 器官腔隙感染在靶向抗生素组更低(RR 0.54,P=0.0004)。
- 肠球菌属是报告的最常见细菌。
临床怎么用
- 在胰十二指肠切除术围手术期,可考虑使用靶向抗生素以降低SSI风险。
- 靶向抗生素的选择应针对胆道器械操作相关微生物或基于培养数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Infectious complications are common after pancreatoduodenectomy, which in turn are associated with preoperative biliary drainage. Current guidelines recommend a first-generation cephalosporin as perioperative antibiotic prophylaxis. However, some studies support the use of targeted antibiotics. The aim of this systematic review and meta-analysis is to evaluate the role of prophylactic targeted antibiotics compared to standard antibiotics in reducing postoperative infections after pancreatoduodenectomy. METHODS: A search from MEDLINE, EMBASE, and Cochrane library from 1946 to July 2020 was conducted. Studies were included if they compared targeted antibiotics with standard perioperative antibiotics while including outcome data on surgical site infections (SSI). Targeted therapy was defined as perioperative antibiotics targeting organisms prevalent in bile instrumentation or by culture data obtained from the patient or institution. Outcomes assessed were the rate of SSIs and their microbiology profile. Analyses included demographic data, perioperative antibiotics, postoperative outcomes including microbiology data, and meta-analysis was performed where applicable. RESULTS: Seven studies were included, with a total of 849 patients undergoing pancreatoduodenectomy. Targeted antibiotics were associated with a significantly lower rate of postoperative SSI compared to standard antibiotic therapy [21.1% vs 41.9%; risk ratios (RR) 0.55, 95% confidence interval 0.37-0.81]. Wound/incisional site infections and organ space infections were lower in patients receiving targeted antibiotic prophylaxis (RR 0.33, P = 0.0002 and RR 0.54, P = 0.0004, respectively). Enterococcus species were the most common bacteria reported. CONCLUSION: There was a significant reduction in overall SSI rates when targeted antibiotics was used. Current standard antibiotic prophylaxis is inadequate in covering microbes prevalent in postoperative infections developing after pancreatoduodenectomy.
引用
- Pham H, Chen A, Nahm CB, et al. The Role of Targeted Versus Standard Antibiotic Prophylaxis in Pancreatoduodenectomy in Reducing Postoperative Infectious Complications: A Systematic Review and Meta-analysis. Ann Surg. 2022. PMID: 33630442. doi:10.1097/SLA.0000000000004816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。